- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Risk stratification in clinical trials: a subgroup to be encouraged ; volume:14 ; number:1 ; day:29 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Trials ; 14, Heft 1 (29.11.2013), 1, 11.2013
- Urheber
-
Clayton, Tim
- Beteiligte Personen und Organisationen
-
Pocock, Stuart
SpringerLink (Online service)
- DOI
-
10.1186/1745-6215-14-S1-O104
- URN
-
urn:nbn:de:1111-2016050232182
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2022, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Clayton, Tim
- Pocock, Stuart
- SpringerLink (Online service)
Ähnliche Objekte (12)
Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes
Methods for subgroup selection in biomarker-based clinical trials
Patient stratification in clinical glaucoma trials using the individual tear proteome
Subgroup analyses and investigations of treatment effect heterogeneity in clinical dose-finding trials
Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!
Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification
Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses
Interaction analysis of subgroup effects in randomized trials: the essential methodological points
Managing clinical trials
Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials
Subgroup growth
Hemodialysis dose and frequency should be considered in subgroup analysis
Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes
Methods for subgroup selection in biomarker-based clinical trials
Patient stratification in clinical glaucoma trials using the individual tear proteome
Subgroup analyses and investigations of treatment effect heterogeneity in clinical dose-finding trials
Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!
Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification
Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses
Interaction analysis of subgroup effects in randomized trials: the essential methodological points
Managing clinical trials
Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials
Subgroup growth
Hemodialysis dose and frequency should be considered in subgroup analysis
Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes
Methods for subgroup selection in biomarker-based clinical trials
Patient stratification in clinical glaucoma trials using the individual tear proteome
Subgroup analyses and investigations of treatment effect heterogeneity in clinical dose-finding trials
Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!
Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification
Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses
Interaction analysis of subgroup effects in randomized trials: the essential methodological points
Managing clinical trials
Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials
Subgroup growth